Different miRNA delivery strategies were assayed, consisting of intratumoral injection of cholesterol-conjugated miR-199a/b-3p mimics or AAV vector particles inhibiting tumor growth, decreasing AFP levels, and causing tumor necrosis. The gene discussed is AFP; the disease is neoplasm.